Tamar Bridge News is your trusted guide through the currents of UK news, committed to bridging the gap between information and insight with clarity, precision, and a human-centric approach.
The Court of Appeal (CoA) has upheld the Competition and Markets Authority’s (CMA) finding of cartel infringement in a significant ruling that addresses an illegal market-sharing agreement in the supply of a crucial medicine. The decision overturns a previous ruling by the Competition Appeal Tribunal (CAT) that had set aside the CMA’s original finding on procedural grounds. In July 2021, the CMA concluded that pharmaceutical companies Auden Mckenzie and Actavis UK had engaged in anti-competitive practices by charging excessive prices for hydrocortisone tablets and paying a competitor, AMCo (now Advanz), to remain out of the market. This practice led to…